Teams at Revolution Medicines

Leads global Medical Science Liaison excellence across regions by developing field medical strategies, competency frameworks, onboarding and training programs, performance metrics, insights processes, digital workflows, governance, and compliance standards. Partners with Medical Affairs, Clinical Development, Compliance, and regional teams to improve scientific engagement, operational consistency, launch readiness, inspection preparedness, and overall MSL effectiveness.

Leads global value, market access, and pricing strategy for NSCLC oncology assets. Develops payer value stories, HTA evidence plans, pricing architecture, launch sequencing, and reimbursement strategies. Partners with clinical, HEOR, regulatory, commercial, finance, medical affairs, and regional teams to support development, launch readiness, lifecycle planning, JCA preparation, and payer negotiations across major international markets.

Leads the enterprise strategy, operating model, technical standards, and delivery of real-world analytics and programming across the pharmaceutical product lifecycle. Oversees RWD assessment, RWE study design, statistical analysis, programming, reporting, regulatory support, advanced analytics, data pipelines, governance, resourcing, and team development. Partners with clinical, safety, regulatory, medical affairs, HEOR, market access, commercial, IT, and statistical functions to generate rigorous evidence for oncology development and commercialization decisions.